Evidence map›Paper›PMID 21939589›Full record

ArticleThe international journal of neuropsychopharmacology2012

Varenicline decreases nicotine self-administration and cue-induced reinstatement of nicotine-seeking behaviour in rats when a long pretreatment time is used.

Bernard Le Foll, Munmun Chakraborty-Chatterjee, Shaul Lev-Ran, Chanel Barnes, Abhiram Pushparaj, Islam Gamaleddin, Yijin Yan, Maram Khaled, Steven R Goldberg

Open access · bronzeAbstract read
In one paragraph

Article in The international journal of neuropsychopharmacology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 62 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Identification ofeLife · 2020
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Varenicline Reduces Context-Induced Relapse to Alcohol-Seeking through Actions in the Nucleus Accumbens.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Bernard Le FollTranslational Addiction Research Laboratory, Centre for Addiction and Mental Health, Toronto, Canada. bernard_lefoll@camh.net
Munmun Chakraborty-Chatterjee
Shaul Lev-Ran
Chanel Barnes
Abhiram Pushparaj
Islam Gamaleddin
Yijin Yan
Maram Khaled
Steven R Goldberg
Centre for Addiction and Mental Health · CANational Institute on Drug Abuse · USNational Institutes of Health · US

Funding

Drugs On Learned & Spontaneous Behavior Of Experimental AnimalsZIADA000003 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI SHAHAM, YAVIN · 2009 to 2017
$6.8M
Intramural NIH HHS Z99 DA999999Intramural NIH HHS ZIA DA000003
6 · The paper itself

Abstract

Effects of varenicline (Champix), a nicotinic partial agonist, were evaluated on subjective effects of nicotine (drug discrimination), motivation for nicotine taking (progressive-ratio schedule of intravenous nicotine self-administration) and reinstatement (cue-induced reinstatement of previously extinguished nicotine-seeking behaviour). Effects on motor performance were assessed in rats trained to discriminate nicotine (0.4 mg/kg) from saline under a fixed-ratio (FR 10) schedule of food delivery and in rats trained to respond for food under a progressive-ratio schedule. At short pretreatment times (5-40 min), varenicline produced full or high levels of partial generalization to nicotine's discriminative-stimulus effects and disrupted responding for food, while there were low levels of partial generalization and no disruption of responding for food at 2- or 4-h pretreatment times. Varenicline (1 and 3 mg/kg, 2-h pretreatment time) enhanced discrimination of low doses of nicotine and to a small extent decreased discrimination of the training dose of nicotine. It also dose-dependently decreased nicotine-taking behaviour, but had no effect on food-taking behaviour under progressive-ratio schedules. Finally, varenicline significantly reduced the ability of a nicotine-associated cue to reinstate extinguished nicotine-seeking behaviour. The ability of varenicline to reduce both nicotine-taking and nicotine-seeking behaviour can contribute to its relatively high efficacy in treating human smokers.

Indexed as

CuesAnimalsBenzazepinesConditioning, OperantData Interpretation, StatisticalDiscrimination, PsychologicalDose-Response Relationship, DrugDrug-Seeking BehaviorFeeding BehaviorMaleMotivationNicotineQuinoxalinesRatsRats, Long-EvansRats, Sprague-DawleyBenzazepinesNicotineQuinoxalinesVarenicline

Identifiers

PMID21939589
PMCPMC3707493
OpenAlexW2105124652

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.